Home ›
Breast Cancer Trials ›
NCT07447414
Luminal Breast Cancer Cryoablation
LUBRECA will evaluate the safety and efficacy of cryoablation with liquid nitrogen to treat cT1cN0 luminal breast cancer diagnosed in postmenopausal women
Trial Details
NCT ID NCT07447414
Phase NA
Sponsor Lucía Graña López
Status RECRUITING
Cancer Type Breast Cancer
Interventions Cryoablation with liquid nitrogen (Prosense® system)
Locations (sample) Lugo, Lugo, Spain|43.00992,-7.55602
Key Eligibility Criteria
Postmenopausal women diagnosed with invasive breast cancer by core needle biopsy or vacuum-assisted biopsy Lesion ≤ 2 cm (on ultrasound and contrast enhanced mammography) No axillary lymphadenopathy on ultrasound No axillary lymph node involvement on ultrasound.
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Breast Cancer Trials on Trialify →